SERPINE1 and Genetic thrombotic microangiopathy: Similar to the above, it may be hypothesised that chemotherapy-induced endothelial injury enhances the production and secretion of PAI-1, the most important physiological inhibitor of fibrinolysis, and results in an antifibrinolytic condition that may contribute to the pathogenesis of thrombotic microangiopathy [37].